| JYHB2100136 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-09 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Abraxis Bioscience LLC;Celgene Corporation | Certificate Issued | 2021-08-27 | view |
| JYHB2001322 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2020-08-10 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Corporation;Fresenius Kabi Usa LLC | Filed | 2020-08-21 | view |
| JYHB2001300 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2020-08-07 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2020-08-21 | view |
| JYHB2001299 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2020-08-07 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2020-08-21 | view |
| JYHB2001298 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2020-08-07 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2020-08-21 | view |
| JYHB2001297 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2020-08-07 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2020-08-21 | view |
| JYHB2001296 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-08-07 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Baxter Oncology GmbH | Filed | 2020-08-19 | view |
| JYHB2000429 | Fedratinib胶囊 | fedratinib hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2020-04-15 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Almac Pharma Services Ltd;Celgene Corporation | In Review | 2020-04-14 | view |
| JYHB2000160 | Ozanimod 胶囊 | ozanimod hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2020-02-28 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene International Sarl;Patheon Inc | In Review | 2020-02-27 | view |
| JYHB2000159 | Ozanimod 胶囊 | ozanimod hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2020-02-28 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene International Sarl;Patheon Inc | In Review | 2020-02-27 | view |
| JYHB2000158 | Ozanimod 胶囊 | ozanimod hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2020-02-28 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene International Sarl;Patheon Inc | In Review | 2020-02-27 | view |
| JYHB1800576 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-18 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2018-05-31 | view |
| JYHB1800575 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-18 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2018-05-31 | view |
| JYHB1800574 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-18 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2018-05-31 | view |
| JYHB1800573 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-18 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2018-05-31 | view |
| JYHB1701430 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2017-11-15 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2017-12-04 | view |
| JYHB1701429 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2017-11-15 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2017-12-04 | view |
| JYHB1701428 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2017-11-15 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2017-12-04 | view |
| JYHB1701427 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2017-11-15 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Celgene Europe Ltd;Celgene International Sarl | Filed | 2017-12-04 | view |
| JXSS2100011 | 注射用罗特西普 | luspatercept | Lyophilized | Biological Products(3.1) | Import Drug Application | 2021-02-06 | 新基医药咨询（上海）有限公司 | Xinji Pharmaceutical Consulting (Shanghai) Co Ltd;Patheon Italia SpA;Celgene Corporation | Approval Completed-Pending Certificated | 2022-01-25 | view |
